Evidence map›Paper›PMID 38259955›Full record

ArticlePatient preference and adherence2024

The Burden of Suboptimal Insulin Dosing in People with Diabetes in Spain: Barriers and Solutions from the Physician Perspective.

Virginia Bellido, Natalia Duque, Rachel S Newson, Esther Artime, Erik Spaepen, Miriam Rubio de Santos, Jennifer Redondo-Antón, Silvia Díaz-Cerezo, Jorge Navarro

Open access · goldAbstract read
In one paragraph

Article in Patient preference and adherence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Perceptions of Suboptimal Insulin Dosing from People with Diabetes and Healthcare Professionals in Germany.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Virginia BellidoUnidad de Gestión Clínica de Endocrinología y Nutrición, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
Natalia DuqueMedical Department, Medical Affairs, Eli Lilly and Company, Madrid, Spain.ORCID 0000-0002-9587-0679
Rachel S NewsonNAPAC Real World Evidence, Medical Affairs, Eli Lilly and Company, Sydney, NSW, Australia.
Esther ArtimeMedical Department, Medical Affairs, Eli Lilly and Company, Madrid, Spain.ORCID 0000-0003-4294-6462
Erik SpaepenStatistics, HaaPACS GmbH, Schriesheim, Germany.
Miriam Rubio de SantosMedical Department, Medical Affairs, Eli Lilly and Company, Madrid, Spain.
Jennifer Redondo-AntónMedical Department, Medical Affairs, Eli Lilly and Company, Madrid, Spain.ORCID 0000-0003-2661-5866
Silvia Díaz-CerezoMedical Department, Medical Affairs, Eli Lilly and Company, Madrid, Spain.
Jorge NavarroDepartment of Medicine, University of Valencia, Valencia, Spain.
Eli Lilly (Spain) · ESHospital Universitario Virgen del Rocío · ESUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study aimed to determine physicians' perceptions of the extent of suboptimal insulin dosing and the barriers and solutions to optimal dosing in people with diabetes (PwD) treated with insulin. Methods: A cross-sectional online survey was conducted in four countries with primary care physicians and endocrinologists treating PwD using insulin pens, which included 53 questions on physicians' characteristics and their perceptions of the behaviors of PwD in relation to insulin dosing routines, unmet needs and potential solutions. Analyses were descriptive. Results: Of the 160 physicians (80 primary care physicians, 80 specialists) surveyed in Spain, 58.1% were male and 88.8% had been qualified to practice for more than five years. Most physicians (>65%) indicated that 0-30% of PwD missed or skipped, mistimed, or miscalculated an insulin dose in the last 30 days. Common reasons for these actions were that PwD forgot, were out of their normal routine, were too busy or distracted, or were unsure of how much insulin to take. To optimize insulin dosing, over 75% of physicians considered it very helpful for PwD to have real-time insulin dosing calculation guidance, mobile app reminders, a device automatically recording glucose measurements and/or insulin, having insulin and glucose data in one place, and having the time for more meaningful conversations about insulin dosing routines. Conclusion: According to physicians' perspectives, suboptimal insulin dosing remains common among PwD. This survey highlights the need for integrated and automated insulin dosing support to manage the complexity of insulin treatment, improve communications between PwD and physicians, and ultimately improve outcomes for PwD.

Indexed as

barriersdiabetes mellitusinsulin dosingphysicianssolutionsSpaintype 1 diabetes mellitustype 2 diabetes mellitus

Identifiers

PMID38259955
PMCPMC10800280
OpenAlexW4390917243

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.